Fondazione IRCCS, Istituto Nazionale Tumori, Laboratorio

Milan 20133

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumors

Studies at this site

• Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials — Completed